Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company’s FDA-approved Prescription Drug

Jaguar Health, Inc. today announced that the Company has launched an artificial intelligence-powered web portal for U.S. healthcare professionals to support patient access to Mytesi (crofelemer).